Loading…
Inhibition of hypoxia-inducible transcription factor complex with designed epipolythiodiketopiperazine
Designed small molecule inhibitors of hypoxia‐inducible gene expression have potential to become new research tools for molecular biology, genetics and serve as leads to new therapeutics. We report design, synthesis evaluation of biological activity, and a preliminary mechanistic study of epipolythi...
Saved in:
Published in: | Biopolymers 2011-01, Vol.95 (1), p.8-16 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Designed small molecule inhibitors of hypoxia‐inducible gene expression have potential to become new research tools for molecular biology, genetics and serve as leads to new therapeutics. We report design, synthesis evaluation of biological activity, and a preliminary mechanistic study of epipolythiodiketopiperazine (ETP) transcriptional antagonist that targets the interaction between the C‐terminal transactivation domain (C‐TAD) of hypoxia‐inducible factor 1α (HIF‐1α) and cysteine‐histidine rich region (CH1) of transcriptional coactivator p300/CBP. Our results indicate that in cultured cells synthetic ETP 3 disrupts the structure and function of this complex in a dose‐dependent manner, resulting in rapid downregulation of hypoxia‐inducible gene expression. © 2010 Wiley Periodicals, Inc. Biopolymers 95: 8–16, 2011. |
---|---|
ISSN: | 0006-3525 1097-0282 1097-0282 |
DOI: | 10.1002/bip.21550 |